Xiaoping Qian

机构：Nanjing Drum Tower Hospital, Jiangsu Cancer Hospital

发表论文 90 篇 · 总被引 1292 次 · h-index 22

代表论文

• PD-1 blockade plus chemoradiotherapy as preoperative therapy for patients with BRPC/LAPC: A biomolecular exploratory, phase II trial (2023 · Cell Reports Medicine · 被引 38)
• Safety, Pharmacokinetic and Clinical Activity of Intrathecal Chemotherapy With Pemetrexed via the Ommaya Reservoir for Leptomeningeal Metastases From Lung Adenocarcinoma: A Prospective Phase I Study (2022 · Clinical Lung Cancer · 被引 34)
• Biomarkers for predicting tumor response to PD-1 inhibitors in patients with advanced pancreatic cancer (2023 · Human Vaccines & Immunotherapeutics · 被引 29)
• SLAMF8, a potential new immune checkpoint molecule, is associated with the prognosis of colorectal cancer (2023 · Translational Oncology · 被引 22)
• Enzymatically responsive nanocarriers targeting PD-1 and TGF-β pathways reverse immunotherapeutic resistance and elicit robust therapeutic efficacy (2025 · Journal of Nanobiotechnology · 被引 20)
• Nanomodified Switch Induced Precise and Moderate Activation of CAR‐T Cells for Solid Tumors (2023 · Advanced Science · 被引 19)